These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36958106)

  • 1. Serum levels of matrix metalloproteinase 2 and its inhibitor after tonic-clonic seizures.
    Cudna A; Bronisz E; Mirowska-Guzel D; Kurkowska-Jastrzębska I
    Epilepsy Res; 2023 May; 192():107115. PubMed ID: 36958106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in serum blood-brain barrier markers after bilateral tonic-clonic seizures.
    Cudna A; Bronisz E; Jopowicz A; Kurkowska-Jastrzębska I
    Seizure; 2023 Mar; 106():129-137. PubMed ID: 36841062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
    Li YJ; Wang ZH; Zhang B; Zhe X; Wang MJ; Shi ST; Bai J; Lin T; Guo CJ; Zhang SJ; Kong XL; Zuo X; Zhao H
    J Neuroinflammation; 2013 Jul; 10():80. PubMed ID: 23829879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Brain Barrier-Associated Proteins Are Elevated in Serum of Epilepsy Patients.
    Bronisz E; Cudna A; Wierzbicka A; Kurkowska-Jastrzębska I
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metalloproteinase 9 levels increase after generalized tonic-clonic seizures.
    Cudna A; Jopowicz A; Mierzejewski P; Kurkowska-Jastrzębska I
    Epilepsy Res; 2017 Jan; 129():33-36. PubMed ID: 27886560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of serum brain-derived neurotrophic factor (BDNF) concentration levels in epileptic patients after generalized tonic-clonic seizures.
    Poniatowski ŁA; Cudna A; Kurczych K; Bronisz E; Kurkowska-Jastrzębska I
    Epilepsy Res; 2021 Jul; 173():106612. PubMed ID: 33774427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for peri-ictal blood-brain barrier dysfunction in patients with epilepsy.
    Rüber T; David B; Lüchters G; Nass RD; Friedman A; Surges R; Stöcker T; Weber B; Deichmann R; Schlaug G; Hattingen E; Elger CE
    Brain; 2018 Oct; 141(10):2952-2965. PubMed ID: 30239618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Proteins Associated with Blood-Brain Barrier as Potential Biomarkers for Seizure Prediction.
    Bronisz E; Cudna A; Wierzbicka A; Kurkowska-Jastrzębska I
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures.
    Nass RD; Wagner M; Surges R; Holdenrieder S
    Epilepsy Res; 2020 May; 162():106301. PubMed ID: 32126476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accidental injuries in patients with generalized tonic-clonic seizures. A multicenter, observational, cross-sectional study (QUIN-GTC study).
    Salas-Puig X; Iniesta M; Abraira L; Puig J;
    Epilepsy Behav; 2019 Mar; 92():135-139. PubMed ID: 30658321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.
    Rempe RG; Hartz AMS; Soldner ELB; Sokola BS; Alluri SR; Abner EL; Kryscio RJ; Pekcec A; Schlichtiger J; Bauer B
    J Neurosci; 2018 May; 38(18):4301-4315. PubMed ID: 29632167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of muscle activation during generalized tonic and tonic-clonic epileptic seizures.
    Conradsen I; Wolf P; Sams T; Sorensen HB; Beniczky S
    Epilepsia; 2011 Nov; 52(11):2125-32. PubMed ID: 21973264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M; Zampachová E; Elsterová J; Růžek D
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and alpha2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids.
    Vogt J; Andersen VL; Andreasen A; Obel T; Christensen JH; Schmidt EB
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):102-9. PubMed ID: 20196974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
    Suenaga N; Ichiyama T; Kubota M; Isumi H; Tohyama J; Furukawa S
    J Neurol Sci; 2008 Mar; 266(1-2):126-30. PubMed ID: 17928006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures.
    Kittaka S; Hasegawa S; Ito Y; Ohbuchi N; Suzuki E; Kawano S; Aoki Y; Nakatsuka K; Kudo K; Wakiguchi H; Kajimoto M; Matsushige T; Ichiyama T
    J Infect Chemother; 2014 Nov; 20(11):716-21. PubMed ID: 25156011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.
    Takács E; Nyilas R; Szepesi Z; Baracskay P; Karlsen B; Røsvold T; Bjørkum AA; Czurkó A; Kovács Z; Kékesi AK; Juhász G
    Neurochem Int; 2010; 56(6-7):799-809. PubMed ID: 20303372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines.
    Krizanac-Bengez L; Hossain M; Fazio V; Mayberg M; Janigro D
    Am J Physiol Cell Physiol; 2006 Oct; 291(4):C740-9. PubMed ID: 16707552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the immature rat model of febrile seizures on the occurrence of later generalized tonic-clonic and absence epilepsy.
    Ateş N; Akman O; Karson A
    Brain Res Dev Brain Res; 2005 Jan; 154(1):137-40. PubMed ID: 15617762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.